Prognostic factors for overall survival of patients with advanced renal cell carcinoma – data from the German prospective RCC-Registry. Goebell, P.J., Müller, L., Staehler, M., Müller, Frank, M., Kruggel, L., Jänicke, M., Marschner, N., 2017. Oncol Res Treat 40 (suppl 3)(V420), 114. Real world effectiveness and safety of pazopanib and everolimus in metastatic renal cell carcinoma: first interim analysis of the PAZOREAL study. Bedke, J., Welslau, M., Boegemann, M., Schostak, M., Hering-Schubert, C., Petzoldt, A., Wolf, T., Schleicher, J., Doehn, C., Grüllich, C., Grünwald, V., Steiner, T., Ehneß,… Weiterlesen Treatment sequences in patients with advanced or metastatic pancreatic cancer in German outpatient cancer centers – data from the TPK clinical cohort study. Hegewisch-Becker, S., Aldaoud, A., Lerchenmüller, C., Scheiner-Sparna, R., Jänicke, M., Hamm, D., Marschner, N., 2017. Oncol Res Treat 40 (suppl 3)(P825), 235. Weiterlesen